{"id":6053,"date":"2024-01-31T15:04:37","date_gmt":"2024-01-31T15:04:37","guid":{"rendered":"https:\/\/www.scottishmesotheliomanetwork.scot.nhs.uk\/?page_id=6053"},"modified":"2024-02-12T15:58:08","modified_gmt":"2024-02-12T15:58:08","slug":"mitope","status":"publish","type":"page","link":"https:\/\/www.nn.nhs.scot\/scottishmesotheliomanetwork\/professionals\/clinical-trial\/mitope\/","title":{"rendered":"MITOPE"},"content":{"rendered":"\n<p id=\"_4lvnXV04tpNiF1\">The MITOPE trial is now opened in the Queen Elizabeth University Hospital.<\/p>\n\n\n\n<p id=\"_dNNe5ve2XE5Oek\">This clinical trial offers a new treatment option for MPE and mesothelioma patients using RS Oncology\u2019s novel drug known as RSO-021. This new drug targets a specific mitochondrial enzyme (PRX3) by regulating oxidative stress to eliminate cancer cells while sparing normal cells. RSO-021 is administered weekly locally into the pleural cavity using an intrapleural catheter immediately after the pleural effusion is drained.<\/p>\n\n\n\n<p id=\"_cvsKeGvXp5AgWU\">This clinical trial is available to patients who are at least 18 years old suffering from MPE and\/or mesothelioma, and have documented tumor progression after receiving at least one prior standard of care treatment.&nbsp; The trial will also soon be widening to include patients who had not had any treatment as a first line option.<\/p>\n\n\n\n<p id=\"_XBe9TNlNfl9I6K\">For more information please contact&nbsp;<a class=\"mail-link\" data-enc-email=\"pnebyla.znpenr[at]ttp.fpbg.auf.hx\" data-wpel-link=\"ignore\"><span id=\"wpmt-169066-355605\">carolyn.macrae@ggc.scot.nhs.uk<\/span><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p class=\"nhsuk-card__description\">The MITOPE trial is now opened in the Queen Elizabeth University Hospital. This clinical trial offers a new treatment option [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":0,"parent":2873,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-6053","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.nn.nhs.scot\/scottishmesotheliomanetwork\/wp-json\/wp\/v2\/pages\/6053","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.nn.nhs.scot\/scottishmesotheliomanetwork\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.nn.nhs.scot\/scottishmesotheliomanetwork\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.nn.nhs.scot\/scottishmesotheliomanetwork\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.nn.nhs.scot\/scottishmesotheliomanetwork\/wp-json\/wp\/v2\/comments?post=6053"}],"version-history":[{"count":2,"href":"https:\/\/www.nn.nhs.scot\/scottishmesotheliomanetwork\/wp-json\/wp\/v2\/pages\/6053\/revisions"}],"predecessor-version":[{"id":6238,"href":"https:\/\/www.nn.nhs.scot\/scottishmesotheliomanetwork\/wp-json\/wp\/v2\/pages\/6053\/revisions\/6238"}],"up":[{"embeddable":true,"href":"https:\/\/www.nn.nhs.scot\/scottishmesotheliomanetwork\/wp-json\/wp\/v2\/pages\/2873"}],"wp:attachment":[{"href":"https:\/\/www.nn.nhs.scot\/scottishmesotheliomanetwork\/wp-json\/wp\/v2\/media?parent=6053"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}